← All companies

PRTA Prothena Corporation plc Ordinary Shares

PHARMACEUTICAL PREPARATIONS · $412M market cap · updated 2026-10-07
Market price
$8.02
Avg intrinsic value
$4.95
Margin of safety
-38.3%

Three independent discounted-cash-flow-style models value Prothena Corporation plc Ordinary Shares every trading day. 0 of 3 currently price PRTA above its market price.

Model estimates

Free Cash Flow model$5.41
Excess Profit model$4.48
Residual Earnings model$-0.31
Dividend Discount model—

Quality snapshot

Piotroski F-Score2 / 9
Return on invested capital-85.4%
Net debt / EBITDA—
Gross margin+100.0%
Revenue CAGR-43.6%
Cash conversion—
Dividend yield—
Buyback yield-0.1%

Run your own numbers

These are StockKitty's default assumptions. In the app, the models recompute live as you adjust growth, discount rates, and margins — and the AI explains the bull case, bear case, and quality picture.

Open PRTA in StockKitty

Same sector